Media

Academic Research, Media Coverage and Press Releases

Media Coverage

Articles & Interviews

Blog
Bloomberg: IPOX® CEO Josef Schuster Comments on Market Risks Amid Quiet IPO Week featuring HMH
Bloomberg: IPOX® CEO Josef Schuster Comments on Market Risks Amid Quiet IPO Week featuring HMH
Reuters: IPOX® CEO Josef Schuster Discusses Energy Sector Resilience Amid HMH Holding’s US IPO
Reuters: IPOX® CEO Josef Schuster Discusses Energy Sector Resilience Amid HMH Holding’s US IPO
Reuters: IPOX® CEO Josef Schuster Comments on AEVEX's IPO Filing and Defense Sector Growth
Reuters: IPOX® CEO Josef Schuster Comments on AEVEX's IPO Filing and Defense Sector Growth
Nikkei: IPOX® CEO Josef Schuster Weighs in on PayPay's $12.1 Billion U.S. Nasdaq Listing
Nikkei: IPOX® CEO Josef Schuster Weighs in on PayPay's $12.1 Billion U.S. Nasdaq Listing
Reuters: IPOX® Research Associate Lukas Muehlbauer Comments on PayPay's Nasdaq Debut
Reuters: IPOX® Research Associate Lukas Muehlbauer Comments on PayPay's Nasdaq Debut
Reuters: IPOX® Research Associate Lukas Muehlbauer Comments on MiniMed's Nasdaq Debut Amid Market Volatility
Reuters: IPOX® Research Associate Lukas Muehlbauer Comments on MiniMed's Nasdaq Debut Amid Market Volatility
Bloomberg: IPOX® Associate Muehlbauer Comments on the Surge of European Defense IPOs
Bloomberg: IPOX® Associate Muehlbauer Comments on the Surge of European Defense IPOs
Reuters: IPOX® CEO Josef Schuster Comments on PayPay's $13.4 Billion U.S. IPO
Reuters: IPOX® CEO Josef Schuster Comments on PayPay's $13.4 Billion U.S. IPO
Reuters: IPOX® Research Associate Lukas Muehlbauer Comments on MiniMed's $7.9 Billion IPO Valuation
Reuters: IPOX® Research Associate Lukas Muehlbauer Comments on MiniMed's $7.9 Billion IPO Valuation
Reuters: IPOX® Research Associate Muehlbauer Comments on Generate Biomedicines' IPO
Reuters: IPOX® Research Associate Muehlbauer Comments on Generate Biomedicines' IPO
Reuters: IPOX® VP Kat Liu Comments on Clear Street’s Withdrawn IPO Amid Market Volatility
Reuters: IPOX® VP Kat Liu Comments on Clear Street’s Withdrawn IPO Amid Market Volatility
Bloomberg: IPOX® Associate Muehlbauer Comments on European IPOs and Follow-On Offerings
Bloomberg: IPOX® Associate Muehlbauer Comments on European IPOs and Follow-On Offerings
Reuters: IPOX® Research Associate Muehlbauer Comments on Liftoff Mobile's Withdrawn IPO Plans
Reuters: IPOX® Research Associate Muehlbauer Comments on Liftoff Mobile's Withdrawn IPO Plans
Reuters: IPOX® VP Kat Liu on ARKO Petroleum’s Nasdaq Debut and Market Volatility
Reuters: IPOX® VP Kat Liu on ARKO Petroleum’s Nasdaq Debut and Market Volatility
Reuters: IPOX® Research Associate Lukas Muehlbauer comments on Clear Street’s Slashed IPO Target
Reuters: IPOX® Research Associate Lukas Muehlbauer comments on Clear Street’s Slashed IPO Target
Reuters: IPOX® Associate Muehlbauer Comments on Agibank's Downsized IPO
Reuters: IPOX® Associate Muehlbauer Comments on Agibank's Downsized IPO
Bloomberg: IPOX® Associate Muehlbauer Featured in Coverage of Saudi IPO Retail Push
Bloomberg: IPOX® Associate Muehlbauer Featured in Coverage of Saudi IPO Retail Push
Reuters: IPOX® Associate Muehlbauer on Agomab’s Nasdaq Debut Amid Biotech Selectivity
Reuters: IPOX® Associate Muehlbauer on Agomab’s Nasdaq Debut Amid Biotech Selectivity
Reuters: IPOX® Associate Muehlbauer Comments on Forgent Power's NYSE Debut
Reuters: IPOX® Associate Muehlbauer Comments on Forgent Power's NYSE Debut
Reuters: IPOX® Associate Lukas Muehlbauer comments on York Space Systems’ NYSE Debut
Reuters: IPOX® Associate Lukas Muehlbauer comments on York Space Systems’ NYSE Debut
Reuters: IPOX® Associate Lukas Muehlbauer analyzes Eikon Therapeutics' Strategic Positioning and IPO Launch
Reuters: IPOX® Associate Lukas Muehlbauer analyzes Eikon Therapeutics' Strategic Positioning and IPO Launch
Bloomberg: IPOX® CEO Josef Schuster Comments on Risks of Celebrity-Backed IPOs
Bloomberg: IPOX® CEO Josef Schuster Comments on Risks of Celebrity-Backed IPOs
Reuters: IPOX® VP Kat Liu comments on Tariff Risks in Bob's Discount Furniture IPO
Reuters: IPOX® VP Kat Liu comments on Tariff Risks in Bob's Discount Furniture IPO
Reuters: IPOX® Associate Lukas Muehlbauer comments on Forgent Power’s AI-Driven IPO Valuation
Reuters: IPOX® Associate Lukas Muehlbauer comments on Forgent Power’s AI-Driven IPO Valuation
Reuters: IPOX® Research Associate Lukas Muehlbauer Comments on EquipmentShare’s Nasdaq Debut
Reuters: IPOX® Research Associate Lukas Muehlbauer Comments on EquipmentShare’s Nasdaq Debut
Reuters: IPOX® Associate Muehlbauer Analyzes BitGo's Debut Amidst Crypto Market Headwinds
Reuters: IPOX® Associate Muehlbauer Analyzes BitGo's Debut Amidst Crypto Market Headwinds
Benzinga: IPOX®-linked ETFs FPX and FPXI Highlighted as IPO Market Heats Up in January 2026
Benzinga: IPOX®-linked ETFs FPX and FPXI Highlighted as IPO Market Heats Up in January 2026
Barron's: IPOX® CEO Josef Schuster Comments on BitGo's IPO and Market Selectivity
Barron's: IPOX® CEO Josef Schuster Comments on BitGo's IPO and Market Selectivity
Reuters: IPOX® VP Kat Liu Comments on EquipmentShare.com’s $6.4 Billion IPO Target
Reuters: IPOX® VP Kat Liu Comments on EquipmentShare.com’s $6.4 Billion IPO Target
Reuters: IPOX® Associate Muehlbauer Comments on BitGo's $1.96 Billion IPO Target
Reuters: IPOX® Associate Muehlbauer Comments on BitGo's $1.96 Billion IPO Target

Videos

Blog
Josef Schuster on the IPOX ETFs (TD Ameritrade)
Josef Schuster on the IPOX ETFs (TD Ameritrade)
Josef Schuster on the Airbnb IPO (Yahoo Finance)
Josef Schuster on the Airbnb IPO (Yahoo Finance)
U.S. IPO market expected to see more unicorns: IPOX Schuster (BNN Bloomberg)
U.S. IPO market expected to see more unicorns: IPOX Schuster (BNN Bloomberg)
IPOs in the Global Capital Markets (LSE)
IPOs in the Global Capital Markets (LSE)
Japan Post Financial Units to Outperform, Schuster Says (Bloomberg TV)
Japan Post Financial Units to Outperform, Schuster Says (Bloomberg TV)
Josef Schuster talks about tech market trends (CGTN America)
Josef Schuster talks about tech market trends (CGTN America)
Josef Schuster weighs in on Alibaba (CGTN America)
Josef Schuster weighs in on Alibaba (CGTN America)

 Press Releases

Academic Research

Blog
FPX_Defensive_Growth_Jan_2023-1.jpg
IPOX® Research: Achieving real returns in stagflationary periods
The IPOX® SPAC Research - U.S. SPAC Market Review and Outlook Q1 2022
The IPOX® SPAC Research - U.S. SPAC Market Review and Outlook Q1 2022
The IPOX® SPAC Research – U.S. SPAC Market Review and Outlook, FY 2021
The IPOX® SPAC Research – U.S. SPAC Market Review and Outlook, FY 2021
Factor Exposures for the IPOX® Portfolio 2020
Factor Exposures for the IPOX® Portfolio 2020
Factor Exposures for the IPOX® Portfolio 2019
Factor Exposures for the IPOX® Portfolio 2019
Navigating the IPO Market with IPOX® IPO Indexes
Navigating the IPO Market with IPOX® IPO Indexes
The Cross-Section of European IPO Returns
The Cross-Section of European IPO Returns
The Case for Indexing Chinese IPOs
The Case for Indexing Chinese IPOs
IPOs: Insights from Seven European Countries
IPOs: Insights from Seven European Countries
Do IPO index portfolios improve the investment opportunities for mean–variance investors?
Do IPO index portfolios improve the investment opportunities for mean–variance investors?